Cancer drugs under scrutiny for hidden heart risks
NCT ID NCT06332131
Summary
This study aims to understand how a common type of cancer immunotherapy might affect the heart's smallest blood vessels. Researchers will follow 25 adults with breast or lung cancer who are starting this treatment. They will use heart scans and blood tests to monitor for changes in blood flow and heart health over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.